APA (7th ed.) Citation

Lu, T., Chang, W., Chan, C., & Wu, S. (2019). Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor. Frontiers in Pharmacology, 10, . https://doi.org/10.3389/fphar.2019.00076

Chicago Style (17th ed.) Citation

Lu, Te-Ling, Wei-Ting Chang, Chee-Hong Chan, and Sheng-Nan Wu. "Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor." Frontiers in Pharmacology 10 (2019). https://doi.org/10.3389/fphar.2019.00076.

MLA (9th ed.) Citation

Lu, Te-Ling, et al. "Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor." Frontiers in Pharmacology, vol. 10, 2019, https://doi.org/10.3389/fphar.2019.00076.